Sunday, October 24, 2021
- Advertisement -spot_img



US begins clinical trial to test immune modulators for COVID treatment

"The trial, known as ACTIV-1 Immune Modulators, will determine if the therapeutics are able to restore balance to an overactive immune system."

Hetero launches patient-friendly Favivir pack for Covid-19 treatment

Hyderabad: Hyderabad-based generic pharmaceuticals company Hetero launched its ‘patient compliant pack’ of Favivir 800/200 for the treatment of mild-to-moderate symptomatic Covid-19 patients in India. Favivir...

Saptagir Laboratories enters into exclusive agreement with Jubilant Generics

“This partnership is timely and in line with our strategic growth plans for the company."

Saptagir Laboratories to manufacture Remdesivir for Jubilant Generics

Hyderabad-based company signs an exclusive agreement to make intermediates and bulk drugs for intravenous administered drug

Dr Reddy’s launches Redyx for treatment of Covid-19 patients

Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of Covid-19 patients hospitalised with severe symptoms. Redyx is available in a strength of 100 mg vial.

Zydus Cadila launches COVID-19 drug Remdesivir in India

Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing.

Investigational therapies off-label remedy

Doctors caution that plasma therapy is not a silver bullet to treat Covid patients as there is no clear mortality benefit of it

Advantage Hyderabad

Of the 6 Indian biotech firms engaged in vaccine development, four are in Hyderabad, signifying the importance of the city in this critical area

Don’t press the panic button: AIG chief

AIG chairman Dr D Nageshwar Reddy urges people not to get overly worried or depressed because there is an end to the ongoing Covid wave

Telangana’s health, DCA wings join hands for vital drugs

Aim to ensure adequate supply of antivirals and steroids to treat Covid-19 patients

Telangana to launch mobile Covid-19 testing centres

The mobile Covid-19 testing buses along with ambulances and trained personnel will visit the containment zones

Canada authorises remdesivir to treat patients of severe Covid-19

Remdesivir is the first drug that Canada has authorised for the treatment of Covid-19, according to a press release on Tuesday from Health Canada, Xinhua reported.

Four held for profiteering on Covid drugs in Hyderabad

Rachakonda CP requested citizens to complaints against those selling medicines and oxygen cylinders for higher rates on Dial-100 or Rachakonda WhatsApp No- 9490617111

Mylan launches generic version of Remdesivir in India

The drug is approved for the treatment of suspected or laboratory confirmed incidences of Covid-19 in adults and children hospitalised with severe presentations of the disease

Seven held in Hyderabad for illegal sale of Covid-19 drugs

The seven persons were procuring generic versions of Remdesivir and Cipremi injections and selling the same at higher prices to Covid-19 patients and making huge money, police said.

Hyderabad: Pharmacist arrested for selling Rs.5,400-Remdesivir at Rs.21,000

A resident of Golconda, Sikander Ali Khan, 29, had complained to the police on Tuesday that he purchased three Remdesivir injections from one medical store near the NIMS hospital for his relative who is taking treatment for Covid-19.

Remdesivir linked to reduced death risk in severe Covid-19 patients

This is an important finding that requires confirmation in prospective clinical trials, Gilead said on Friday about the results presented at the virtual COVID-19 conference as part of the 23rd International AIDS Conference

Cipla’s Covid-19 drug Cipremi set to cost less than Rs 5K per vial

Gilead Sciences extended a voluntary non-exclusive license to Cipla in May to manufacture and market Cipla's generic version of remedisvir called Cipremi.

Hetero all set to supply 20,000 vials of Covifor pan-India

One of which, will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, while the other lot will be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar.

Hyderabad-based Hetero gets approval for first generic Remdesivir

Dr B Partha Saradhi Reddy, chairman, Hetero Group of Companies, said, “In the light of increasing Covid-19 cases in India, the approval of ‘Covifor’ (Remdesivir) can prove to be a game-changer given its positive clinical outcomes.

Latest news

- Advertisement -spot_img
Telangana Today